Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
暂无分享,去创建一个
R. Giugliano | M. Sabatine | N. Desai | S. Mohanavelu | P. Kohli | S. Wasserman | R. Scott | Thomas Liu | Elaine B. Hoffman | W. Rogers | Fannie Huang | R. Somaratne | S. McDonald | Timothy E Abrahamsen | Satishkumar Mohanavelu